Chronic aquatic environmental risks from exposure to human pharmaceuticals.
about
Neglected sources of pharmaceuticals in river water--footprints of a Reggae festival.Global synthesis and critical evaluation of pharmaceutical data sets collected from river systemsUse of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals.Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluentsPharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.Review of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking waters.Hepatic proteome analysis of Atlantic salmon (Salmo salar) after exposure to environmental concentrations of human pharmaceuticals.Molecular and Cellular Effects Induced in Mytilus galloprovincialis Treated with Oxytetracycline at Different Temperatures.Assessing the reliability of uptake and elimination kinetics modelling approaches for estimating bioconcentration factors in the freshwater invertebrate, Gammarus pulex.In vivo solid-phase microextraction for tissue bioanalysis.The degradation behaviour of nine diverse contaminants in urban surface water and wastewater prior to water treatment.Risk assessment of chlortetracycline, oxytetracycline, sulfamethazine, sulfathiazole, and erythromycin in aquatic environment: are the current environmental concentrations safe?Do antibiotics have environmental side-effects? Impact of synthetic antibiotics on biogeochemical processes.Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment.Effluent-dominated streams. Part 2: Presence and possible effects of pharmaceuticals and personal care products in Wascana Creek, Saskatchewan, Canada.Individual and mixture toxicity of pharmaceuticals naproxen, carbamazepine, and sulfamethoxazole to Australian striped marsh frog tadpoles (Limnodynastes peronii).Comparing the sensitivity of chlorophytes, cyanobacteria, and diatoms to major-use antibiotics.Effects and interactions in an environmentally relevant mixture of pharmaceuticals.Effects of Antibiotics on the Growth and Physiology of Chlorophytes, Cyanobacteria, and a Diatom.Effect of organic toxicants on the activity of denitrifying granular sludge.Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland.Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater.Biodegradation of drotaverine hydrochloride by free and immobilized cells of Rhodococcus rhodochrous IEGM 608.Biomarker assessment of toxicity with miniaturised bioassays: diclofenac as a case study.Ecotoxicological risk assessment of chosen pharmaceuticals detected in surface waters.Individual and mixture effects of caffeine and sulfamethoxazole on the daggerblade grass shrimp Palaemonetes pugio following maternal exposure.Biochemical and standard toxic effects of acetaminophen on the macrophyte species Lemna minor and Lemna gibba.Pharmacopollution and Household Waste Medicine (HWM): how reverse logistics is environmentally important to Brazil.Presence of active pharmaceutical ingredients in the continuum of surface and ground water used in drinking water production.Drugs of environmental concern modify Solea senegalensis physiology and biochemistry in a temperature-dependent manner.Pharmaceuticals in the environment: an educational perspective.In Silico Models for Ecotoxicity of Pharmaceuticals.The individual and population effects of tetracycline on Daphnia magna in multigenerational exposure.Toxicity evaluation of verapamil and tramadol based on toxicity assay and expression patterns of Dhb, Vtg, Arnt, CYP4, and CYP314 in Daphnia magna.Environmental impact of switching from the synthetic glucocorticoid prednisolone to the natural alkaloid berberine.Living with eutrophication in South Africa: a review of realities and challengesPollution in mediterranean-climate riversTowards rational molecular design for reduced chronic aquatic toxicityEnvironmental Risk Assessment of PharmaceuticalsExperimental manipulation of monoamine levels alters personality in crickets
P2860
Q30557322-0CC3B683-F077-4BE0-AA99-B0CF4E8FD287Q30580997-CE7C4B48-665B-44D2-A60E-417A7434E227Q30996886-241AD9B2-73D1-4D54-9B1B-E0E1AAEAAFFDQ33947011-75CA967E-26E3-40FC-A0E0-959CFE7A4C55Q34296925-FB6F9D4F-AD9E-4DD6-BA13-3252C54E8C57Q34983685-5D3AD03C-3DD1-49BE-B35D-07044BCF5D37Q35148568-51B6D0EF-FB56-4162-908E-C03702ADF55FQ35661520-5517D660-6B9B-4375-9131-8167BA79DC94Q37116544-195D9183-36E5-4186-AD64-3C01481772E8Q38061685-3C032B2C-9FC9-4DC1-A517-142674429B07Q38385248-DC004555-40BC-49E3-AE41-82C644169DAEQ38424140-8C7F2EC6-3890-4C07-8B86-0373F94C1F20Q38543473-D3A2B142-B7CA-4696-8B18-1FB1FA362982Q38917403-7FE3BD16-05F8-4F01-A352-3712C4CB8F86Q39112389-8BCC1FD9-55CA-4F86-9861-21BB940D912AQ39239569-B0497BAF-86FF-4B2E-9F69-DA4F7B13A1D9Q39909226-A604E6A9-7DF9-4155-8875-D99029484432Q40042518-2FB57A8C-3625-443A-8B48-3039DC588E0AQ41482166-16098616-D933-4A99-A2DF-B182010C57CAQ43323156-7B118AFD-7693-43B7-BF0C-BB7C158CD6B8Q43328441-251D29AF-DD50-4C4A-9FF8-94A6440F87E5Q43342175-4DA771D9-559B-4D4F-88F9-162B0C790551Q44448992-8AC0E43E-F407-471C-A310-9D7075488533Q45130296-A5C5E94E-8551-42D8-8855-40B34E218EB1Q46300466-94D51AFD-B7CB-46C4-8C5E-CD9F06F9C9A0Q46316146-B7526842-259F-46E7-9A49-DA6A087B3DB4Q46885456-A51A55F0-5FEF-42CE-9CDB-8D760E7FEEF7Q47686735-642F02EA-3280-4CC0-95FC-A092B9D7B850Q47863288-8AD695EE-7713-44C6-A5CC-A7FA7F1DD9E7Q48128740-467B7D39-4859-437D-A361-99977ABA00BDQ48539174-00AE7F2F-A38E-473A-A516-A1DF83836EB6Q51283587-0D9EF868-DCEB-4EF0-8DF9-5D4A8DDC7E03Q51367447-7455CCD4-1306-441C-AE9F-995F9BCF5732Q51506068-1DED2D1B-4F7C-40DD-A8ED-23E4A4050BFDQ55284130-C9CF0C40-F661-4736-A264-F7746BFE4CDBQ56092683-3BE55702-B616-4559-BFE4-36F97C090F60Q57237595-2B03CCE2-40C2-4C88-96E2-287A3591AC97Q57774814-517C89E4-3E75-437B-A0C6-F7B970B7DE1DQ58240641-8111557B-1CB4-4D73-9D01-3CA6ACA91DC0Q58577636-06A510AA-6BA0-4C98-B465-C28F6338FAC7
P2860
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
@ast
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
@en
type
label
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
@ast
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
@en
prefLabel
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
@ast
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
@en
P2093
P1476
Chronic aquatic environmental risks from exposure to human pharmaceuticals.
@en
P2093
Chris Watts
Mark Crane
Tatiana Boucard
P356
10.1016/J.SCITOTENV.2006.04.010
P577
2006-06-09T00:00:00Z